2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on Advanced CRC: Is Recently FDA Approved Encorafenib + Cetuximab a New SoC for Previously Treated BRAF V600E-mutant mCRC? Can T-DXd Be an Option for HER2+ Disease?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Louise Connell
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Louise Connell
190 views
July 14, 2020
Comments 0
Login to view comments.
Click here to Login
GI